American Vanguard Corp
AVD NYSE Agricultural Chemicals Financials FY2016–FY2025
Last close · Oct 23, 2026
$1.03
2.8%What American Vanguard Corp does
No business description yet.
- Legal name
- AMERICAN VANGUARD CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 16, 2026
- Accession · CIK
- 0001193125-26-108593
0000005981
Revenue and margins
American Vanguard Corp had $515M of revenue in fiscal 2025, down 5.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
American Vanguard Corp returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 1.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably American Vanguard Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $16.3M | $20.3M | $11.4M | $12.5M | $12.4M |
| Debt incl. finance leases | $52.2M | $51.5M | $139M | $147M | $174M |
| Net debt / EBITDA | 0.9x | 0.6x | 4.3x | — | — |
| Debt / equity | 0.1x | 0.1x | 0.4x | 0.6x | 0.9x |
| Interest coverage | 8.4x | 10.3x | 1.8x | −6.1x | −1.5x |
| Current ratio | 1.5x | 1.5x | 1.9x | 1.6x | 1.8x |
| Quick ratio | 0.8x | 0.8x | 0.9x | 0.9x | 0.9x |
| Total assets | $694M | $726M | $768M | $637M | $597M |
| Total liabilities | $321M | $356M | $398M | $404M | $404M |
| Shareholders' equity | $373M | $370M | $370M | $233M | $192M |
| Net debt (− = net cash) | $36.0M | $31.1M | $127M | $135M | $162M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ |
| Return on assets rose | — | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ |
| Debt fell relative to assets | — | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ |
| Current ratio rose | — | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✓ |
| Revenue rose relative to assets | — | ✕ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ |
| F-score | — / 3 | 5 / 9 | 5 / 9 | 4 / 9 | 5 / 9 | 6 / 9 | 8 / 9 | 3 / 9 | 4 / 9 | 5 / 9 |
| Accruals ratio | −7.8% | −8.0% | 2.2% | 0.6% | −11.1% | −9.9% | −4.2% | 8.9% | −18.6% | −4.7% |
| Altman Z'' | 5.98 | 4.76 | 5.01 | 4.64 | 4.33 | 4.07 | 4.04 | 4.32 | 2.09 | 2.80 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $312M | $355M | $454M | $468M | $459M | $558M | $610M | $579M | $547M | $515M |
| Gross profit | $128M | $147M | $183M | $177M | $173M | $171M | $192M | $179M | $120M | $148M |
| Research and development | $21.3M | $26.1M | $26.4M | $24.1M | $26.3M | $28.9M | $31.8M | $38.0M | $32.7M | $23.2M |
| Operating income | $20.5M | $26.8M | $39.0M | $26.2M | $22.9M | $30.9M | $40.7M | $23.3M | −$102M | −$28.3M |
| Interest expense | $1.6M | $1.9M | $4.0M | $7.2M | $5.2M | $3.7M | $4.0M | $12.6M | $16.5M | $18.5M |
| Pretax income | $18.9M | $24.9M | $33.6M | $19.0M | $18.4M | $27.1M | $36.0M | $10.3M | −$120M | −$47.2M |
| Income tax | $5.5M | $4.4M | $9.1M | $5.2M | $3.1M | $8.2M | $8.6M | $2.8M | $5.9M | $2.7M |
| Net income | $12.8M | $20.3M | $24.2M | $13.6M | $15.2M | $18.6M | $27.4M | $7.5M | −$126M | −$49.9M |
| Diluted EPS | $0.44 | $0.68 | $0.81 | $0.46 | $0.51 | $0.61 | $0.92 | $0.26 | −$4.50 | −$1.75 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $46.4M | $59.0M | $11.7M | $9.6M | $90.3M | $86.4M | $57.1M | −$58.7M | $3.9M | −$21.2M |
| Depreciation and amortization | $16.3M | $17.0M | $18.9M | $18.6M | $19.9M | $9.2M | $8.9M | $6.6M | $5.2M | $5.3M |
| Stock-based compensation | $3.2M | $4.7M | $5.8M | $7.2M | $6.6M | $6.9M | $5.7M | $6.1M | $4.4M | $2.0M |
| Acquisitions | $0.2M | $81.9M | $20.0M | $38.0M | $19.3M | $10.0M | $0.0M | $5.2M | $0.0M | $0.0M |
| Share buybacks | — | — | $7.3M | $2.6M | $0.0M | $4.6M | $34.0M | $15.5M | $0.0M | $0.0M |
| Dividends paid | $0.6M | $1.6M | $2.2M | $2.3M | $1.2M | $2.4M | $2.8M | $3.4M | $2.5M | $0.0M |
| Dividends and buybacks | $0.6M | $1.6M | $9.5M | $4.9M | $1.2M | $7.0M | $36.8M | $18.9M | $2.5M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $7.9M | $11.3M | $6.2M | $6.6M | $15.9M | $16.3M | $20.3M | $11.4M | $12.5M | $12.4M |
| Total debt | $41.0M | $77.5M | $96.7M | $149M | $107M | $52.2M | $51.5M | $139M | $147M | $174M |
| Current assets | $227M | $255M | $310M | $336M | $330M | $342M | $389M | $432M | $379M | $371M |
| Current liabilities | $97.1M | $126M | $146M | $139M | $171M | $223M | $267M | $230M | $232M | $209M |
| Inventory | $121M | $123M | $160M | $163M | $164M | $154M | $184M | $220M | $179M | $176M |
| Property and equipment, net | $50.3M | $49.3M | $49.3M | $56.5M | $65.4M | $66.1M | $70.9M | $74.6M | $58.2M | $53.0M |
| Goodwill | — | $22.3M | $25.9M | $46.7M | $52.1M | $46.3M | $47.0M | $51.2M | $19.7M | $0.0M |
| Intangible assets | $121M | $181M | $187M | $198M | $198M | $198M | $185M | $173M | $150M | $139M |
| Total assets | $430M | $536M | $594M | $670M | $680M | $694M | $726M | $768M | $637M | $597M |
| Total liabilities | $148M | $230M | $264M | $326M | $320M | $321M | $356M | $398M | $404M | $404M |
| Preferred stock | — | — | — | — | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $282M | $305M | $329M | $344M | $361M | $373M | $370M | $370M | $233M | $192M |
| Margins | ||||||||||
| Gross margin | 41.1% | 41.5% | 40.2% | 37.9% | 37.6% | 30.6% | 31.6% | 30.9% | 22.0% | 28.6% |
| Operating margin | 6.6% | 7.5% | 8.6% | 5.6% | 5.0% | 5.5% | 6.7% | 4.0% | −18.6% | −5.5% |
| EBITDA margin | 11.8% | 12.3% | 12.7% | 9.6% | 9.3% | 7.2% | 8.1% | 5.2% | −17.6% | −4.5% |
| Net margin | 4.1% | 5.7% | 5.3% | 2.9% | 3.3% | 3.3% | 4.5% | 1.3% | −23.1% | −9.7% |
| Returns | ||||||||||
| Return on capital | 4.6% | 5.9% | 6.8% | 3.9% | 4.2% | 5.3% | 7.7% | 3.4% | −21.8% | −6.3% |
| Return on capital employed | 6.2% | 6.5% | 8.7% | 4.9% | 4.5% | 6.6% | 8.8% | 4.3% | −25.1% | −7.3% |
| Return on equity | 4.5% | 6.9% | 7.6% | 4.0% | 4.3% | 5.1% | 7.4% | 2.0% | −41.9% | −23.4% |
| Return on assets | 3.0% | 4.2% | 4.3% | 2.2% | 2.3% | 2.7% | 3.9% | 1.0% | −18.0% | −8.1% |
| Return on tangible equity | 8.0% | 19.9% | 20.7% | 13.7% | 13.7% | 14.4% | 19.8% | 5.1% | −200.8% | −93.0% |
| Growth | ||||||||||
| Revenue growth | — | 13.8% | 27.9% | 3.1% | −2.0% | 21.6% | 9.3% | −5.0% | −5.5% | −5.9% |
| Net income growth | — | 58.5% | 19.3% | −43.8% | 12.1% | 21.9% | 47.4% | −72.6% | −1,780.3% | — |
| EPS growth | — | 54.5% | 19.1% | −43.2% | 10.9% | 19.6% | 50.8% | −71.7% | −1,830.8% | — |
| Share count change | — | 1.1% | 1.2% | −1.3% | 1.1% | 1.4% | −1.8% | −4.5% | −1.7% | 1.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.9x | 1.5x | 1.6x | 3.2x | 2.1x | 0.9x | 0.6x | 4.3x | — | — |
| Debt / equity | 0.1x | 0.3x | 0.3x | 0.4x | 0.3x | 0.1x | 0.1x | 0.4x | 0.6x | 0.9x |
| Interest coverage | 12.7x | 13.8x | 9.7x | 3.6x | 4.4x | 8.4x | 10.3x | 1.8x | −6.1x | −1.5x |
| Current ratio | 2.3x | 2.0x | 2.1x | 2.4x | 1.9x | 1.5x | 1.5x | 1.9x | 1.6x | 1.8x |
| Quick ratio | 1.1x | 1.0x | 1.0x | 1.2x | 1.0x | 0.8x | 0.8x | 0.9x | 0.9x | 0.9x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 1.0% | 1.3% | 1.3% | 1.5% | 1.4% | 1.2% | 0.9% | 1.1% | 0.8% | 0.4% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 5.0 | 5.0 | 4.0 | 5.0 | 6.0 | 8.0 | 3.0 | 4.0 | 5.0 |
| Altman Z'' | 6.0 | 4.8 | 5.0 | 4.6 | 4.3 | 4.1 | 4.0 | 4.3 | 2.1 | 2.8 |
| Accruals ratio | −7.8% | −8.0% | 2.2% | 0.6% | −11.1% | −9.9% | −4.2% | 8.9% | −18.6% | −4.7% |
Source: SEC EDGAR XBRL filings (CIK 0000005981). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
